High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis

Hypocalcemia is the most common major adverse event in patients with osteoporosis receiving the bone resorption inhibitor denosumab; however, limited information is available regarding risk factors of hypocalcemia. Therefore, this study aimed to identify the risk factors of hypocalcemia induced by d...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ther Clin Risk Manag
Glavni autori: Ishikawa, Koji, Nagai, Takashi, Sakamoto, Keizo, Ohara, Kenji, Eguro, Takeshi, Ito, Hiroshi, Toyoshima, Yoichi, Kokaze, Akatsuki, Toyone, Tomoaki, Inagaki, Katsunori
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2016
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5147395/
https://ncbi.nlm.nih.gov/pubmed/27980413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S123172
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items